Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

246 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-30

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Data collected will include demographic information, family and medical history, as well as lifestyle habits, and the study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Hellenic Postprandial Lipemia Study (HPLS)

NCT02163044

Coronary Heart Disease Dyslipidemia

COMPLETED

A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)

NCT01333436

Dyslipidemia Hypercholesterolemia

COMPLETED NA

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels

NCT05988866

Hypercholesterolemia Dyslipidemias

RECRUITING NA

Effect of Mediterranean Diet in Dyslipidemic Patients

NCT04486664

Dyslipidemias

UNKNOWN NA

The Effect of Childhood Dyslipidemia on Endothelial and Renal Function

NCT03856476

Dyslipidemias Children, Only Endothelial Dysfunction +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lipoprotein(a) \[Lp(a)\] has emerged as a prevalent monogenetic cardiovascular risk factor globally. Despite its significance, clinical attention for elevated Lp(a) is suboptimal. This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece, as well as gather data on the demographic characteristics and medical history of this population. Statistical analysis will assess Lp(a) levels, prevalence, and associations with demographic and cardiovascular risk factors. The study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students, emphasizing the importance of awareness, early diagnosis, and management of this cardiovascular risk factor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Med students

Medical students in whom Lp(a) levels will be measured

Measurement of Lp(a) levels

Intervention Type DIAGNOSTIC_TEST

Collection of a venous blood sample for the measurement of Lp(a) levels using standardized laboratory methods

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurement of Lp(a) levels

Collection of a venous blood sample for the measurement of Lp(a) levels using standardized laboratory methods

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece.

Exclusion Criteria

* Inability/unwillingness to give informed consent

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fotios Barkas

Fotios Barkas, MD, MSc, PhD, Assistant Professor of Internal Medicine Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

Responsibility Role PRINCIPAL_INVESTIGATOR